Orion, Bayer prostate cancer drug gets FDA approval

Finland's Orion and Germany's Bayer said on Wednesday the U.S. Food and Drug Administration (FDA) had approved prostate cancer drug daroluramide, which the two companies have been developing together.


from Reuters: Health News https://ift.tt/2Mu4xKP

Comments

Popular posts from this blog

Man hit with $650K medical bill for emergency back surgery gets relief